REMS Abuse Website: Celgene, Actelion Top List Of Suspected 'Gamers'
Executive Summary
Other sponsors could be using tactics other than REMS abuse to game the system, US FDA Commissioner Scott Gottlieb says.
You may also be interested in...
FDA Lifts Future REMS Burden On Antiretroviral Leaders
As generics of Gilead’s Truvada combination antiretroviral reach the US market, their manufacturers will no longer have to provide risk-mitigation education.
US Ambrisentan Approvals Hint At Different Commercial Approaches
Four different firms have simultaneously received FDA approval for ambrisentan generics of Gilead’s Letairis. But different safety programs suggest Zydus Pharma may be taking a different commercial approach to the other three generics firms.
REMS Website Will Name, Not Shame, Potential Abusers – Gottlieb
US FDA will list number of inquiries about acquiring samples for generic drug development, and also whether FDA sends letters to brand companies telling them it is safe to provide the generic sponsor with the samples.